Conventional thinking proclaims that the Affordable Care Act, a.k.a. Obamacare, is a complete disaster for medical device stocks in part because of a punitive 2.3% excise tax on revenue. This has caused concern among investors and sent companies scrambling to cut costs and protect margins.
In this video, health-care analyst David Williamson looks deeper into some tailwinds that may propel certain medical device stocks higher. Watch and find out where medical device investors living in an Obamacare world should focus their attention.
Follow David on Twitter @MotleyDavid.
